Exclusive
ced pexels 5910773
June 3, 2026
Weight Loss, Metabolic Health, and Psychiatric Safety
ced pexels 11391942
June 3, 2026
Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Diabetes
ced pexels 8670516
June 3, 2026
Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic Patients
ced pexels 30798659
June 3, 2026
Systematic Characterisation of GLP-1R in Human Enteric Nervous System- Implicati
ced pexels 6669396
June 3, 2026
Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia
ced pexels 6643655
June 3, 2026
The No-Hunger Games- How GLP-1 Medication Adoption Is Changing Consumer Food Dem
ced pexels 8846118
June 3, 2026
Beyond weight loss- tirzepatide as a dual GIP:GLP-1 receptor agonist for obstruc
ced pexels 8016897
June 3, 2026
Cancer Incidence Among Users of Glucagon‑Like Peptide‑1 Receptor Agonists
ced pexels 8846404
June 3, 2026
Cannabis policy priorities and public health- a survey of elected officials in California
ced pexels 19794774
June 3, 2026
Clinical Management of Weight Regain and Cardiometabolic Consequences After Discontinuing GLP-1s
ced pexels 8385744
June 3, 2026
Converging neurotrophic-immune signaling in autism spectrum disorder
ced pexels 11264389
June 3, 2026
Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Managemen
ced pexels 19891030
June 3, 2026
Dysesthesia associated with GLP-1 agonist therapies- data-mining analysis
ced pexels 8550990
June 3, 2026
Effects of sub-chronic cannabis smoke exposure on inflammatory markers in serum
ced pexels 5994622
June 3, 2026
Efficacy and safety of GLP-1 receptor agonists in Parkinson’s disease- a systematic review
ced pexels 30885779
June 3, 2026
Ethical Issues Related to the Use of GLP‐1 Receptor Agonists Such as Ozempic and Wegovy and Monjaro
ced pexels 3882517
June 3, 2026
GLP-1 agonists in addiction therapy – review
ced pexels 5042605
June 3, 2026
Safety of GLP-1 receptor agonists in body contouring surgery- a systematic review
ced pexels 17485633
June 3, 2026
SemaGBA- A System Dynamics Model of the Semaglutide-Responsive Gut-Brain Axis
ced pexels 14513405
June 3, 2026
Short-term effect of tirzepatide on serum calcitonin in adults with obesity
ced pexels 7723539
June 3, 2026
GLP-1 RAs and Kidney Cancer Risk- Methodological Considerations in Active-Compara
ced pexels 7904415
June 3, 2026
GLP-1 Receptor Agonists and NAION
ced pexels 8851074
June 3, 2026
GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain
ced pexels 7857897
June 3, 2026
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality
ced pexels 18799752
June 3, 2026
GLP-1 therapies- an emerging approach for alcohol reduction?
ced pexels 6798913
June 3, 2026
GLP‑1 Receptor Agonist Treatment and Health Outcomes in Methadone‑Treated Patien
ced pexels 19357671
June 3, 2026
GLP‑1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum P
ced pexels 7108344
June 3, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Ca
ced pexels 7928141
June 3, 2026
Modes of cannabis administration, cannabis and tobacco co-use, and associations
ced pexels 29702937 1
June 3, 2026
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and
ced pexels 29702937
June 3, 2026
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder- pro
Browse Tag

Childhood Obesity

3 Articles
ced pexels 7653638
GLP-1 Care

GLP-1 Drugs for Childhood Obesity: Access Barriers

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Drugs for Childhood Obesity: Access Barriers
May 9, 2026
6 Min Read

GLP-1 Clinical Relevance  #48Moderate Clinical Relevance  Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryHealthcare AccessChildhood ObesityGLP-1 Receptor AgonistPediatric…

Copyright 2026 — CED Clinic. All rights reserved.